← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Prapela, Inc.
Portland, ME
$6,320,248
Total funding
3
Grants
Funding over time
peak $1.5M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,320,248 · 3
By mechanism
U44$3,460,586 · 1
R44$2,637,437 · 1
R43$222,225 · 1
Investigators at Prapela, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.$1,484,463
U44 · FY2024 · DA
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.$1,475,909
U44 · FY2025 · DA
Prapela⢠SVS: A cost-effective stochastic vibrotactile stimulation device toimprove the clinical course of infants with neonatal abstinence syndrome.$1,330,596
R44 · FY2021 · DA
Prapela⢠SVS: A cost-effective stochastic vibrotactile stimulation device toimprove the clinical course of infants with neonatal abstinence syndrome.$1,169,404
R44 · FY2022 · DA
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.$500,214
U44 · FY2023 · DA
Prapela⢠SVS: A cost-effective stochastic vibrotactile stimulation device to improve the clinical course of infants with neonatal abstinence syndrome.$222,225
R43 · FY2019 · DA
Prapela⢠SVS: A cost-effective stochastic vibrotactile stimulation device toimprove the clinical course of infants with neonatal abstinence syndrome.$137,437
R44 · FY2023 · DA